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Summary
Introduction: To assess serum levels of 25-hydroxyvitamin D-25 (OH) D-hormones with influence on
bone metabolism (parathormone -PTH- and insulin-like growth factor (IGF)-I), bone remodeling markers
(BRM) (carboxy-terminal telopeptide of collagen type I-β-CTX- and amino-peptide pro-peptide of proco-
llagen type I -PINP), bone mineral density (BMD), microstructure and biomechanics of the femoral neck,
in patients with osteoporotic hip fracture (OH) versus arthritic patients (OA).
Material and methods: A cross-sectional observational study of 29 OH and 14 OA, age ≥50 years. We
quantified hormonal serum levels and BRM (immunoassay), hip BMD (DXA), microstructure (micro-CT)
and biomechanics (uniaxial compression tests, IGFA system). Analysis (SPSS 20.0.)
Results: OH patients had lower levels of 25(OH)D (p=0.02) and hip BMD (p<0.05), and higher PTH
(p=0.029) and β-CTX (p=0.04). Levels of 25(OH)D correlated positively with IGF-I (p=0.04) and negati-
vely with β-CTX (p=0.003). The PTH values were correlated negatively with hip BMD (p=0.0005) and
positively with trabecular thickness (TbTh) (p=0.006). Patients with 25(OH)D <20 ng/mL presented hig-
her levels of β-CTX (p=0.006), lower IGF-I (p=0.007) and TbTh (p=0.04).
Conclusions: Vitamin D levels are low in the elderly population, especially in patients with osteoporotic
hip fracture. These patients also presented raised levels of PTH and BRM and descended from BMD.
Patients whose 25(OH)D levels are below 20 ng/mL present higher bone remodeling, with lower levels
of IGF-I and alterations of the bone structure (TbTh) that may be linked to a greater risk of fractures.
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Introduction
Hip fracture is one of the main and most dreaded
complications of osteoporotic disease. Among the
risk factors that favor this type of fracture include
a greater tendency to fall and a decrease in bone
strength. Bone mineral density (BMD), the rate of
bone remodeling, geometry, microstructure and
bone tissue mineralization are fundamental pro-
perties associated with bone resistance1.
Vitamin D is known to be essential, among
other factors, in the maintenance of musculoskele-
tal health. Proper levels of 25-hydroxivitamin D
(25(OH)D) are needed to maintain the homeosta-
sis of calcium metabolism and an insufficiency of
these leads to a lower intestinal absorption of cal-
cium, decreased levels of serum calcium, increa-
sed secretion of PTH, excessive rate of bone
remodeling and, therefore, a lower amount and
bone quality2. Furthermore, levels below 30 ng/mL
have been found to be associated with significant
defects of bone mineralization and increase in the
osteoid substance3. All of these disorders produce
a decrease in bone strength and, thus, a greater
risk of fracture. As for the muscle, several studies
have shown the positive relationship between
25(OH)D levels and muscle strength, especially in
the lower extremities in the elderly4,5. Other rese-
arch indicates muscular weakness and pain, as
characteristic symptoms of Vitamin D-deficient
syndromes6, as well as increased muscle strength
and balance and reduced risk of falls following the
administration of adequate vitamin D supple-
ments7-10. Two meta-analyzes evaluating contro-
lled, double-blind and randomized studies conclu-
de the beneficial effect of vitamin D supplementa-
tion, with a 19% reduction in falls, an 18% risk of
hip fracture and 20% of the risk of any type of
non-vertebral fracture11,12. These same studies
pointed out that anti-fall and antifracture efficiency
of 25(OH) D is achieved when their levels are
above 24 and 30 ng/mL, respectively.
In the adult population, a high frequency of
inadequate levels of vitamin D has been reported,
below a variable threshold that ranges between
20-40 ng/mL of 25(OH)D, according to the diffe-
rent authors, in several studies carried out in mul-
tiple communities in Europe and the United
States13-15. In Spain, this has also been observed in
the elderly population with different characteris-
tics in different regions, with values below 15
ng/mL being described in 68% of 77-year-olds
living at home, compared to 100% of those insti-
tutionalized in Andalusia16, a somewhat lower fre-
quency in Cantabria17, and even lower levels (4.6
ng/mL as mean values) in patients with hip fractu-
re in Madrid18.
These data reveal, on the one hand, the impor-
tance of vitamin D on muscle health and skeletal
integrity and, on the other hand, the frequency of
insufficient levels of the hormone among the adult
population in general. However, the impact of
serum vitamin D levels on the microstructural and
biomechanical characteristics of bone tissue in
patients with hip fracture has not been reported to
date. Therefore, the main objective of our study is
to ascertain if vitamin D levels influence the
microarchitecture and biomechanical properties of
the bone tissue. Secondly, we also analyze the
association of these levels with biochemical mar-
kers of bone remodeling and with hormones that
influence bone formation and resorption (para-
thormone -PTH-, and insulin-like growth factor -
IGF-I-, respectively) parameters, all of which con-
tribute to bone quality and, therefore, the risk of
osteoporotic fracture.
Material and methods 
1. Patients
A cross-sectional observational study of 43
patients aged 50-93 years who underwent hip
arthroplasty. The first group consisted of 29 (6
male and 23 female) patients with nontraumatic
hip fracture (OP), considered as idiopathic (invo-
lutive) osteoporosis. The second, as a comparati-
ve group, consisted of 14 patients (6 men and 8
women) with osteoarthritis (OA) and values of
bone mass, at the hip level, T-score >(-2.5), with
no personal history of fracture Osteoporosis or
disease with influence on bone metabolism.
Normal renal function was required.
All patients were recruited from the
Traumatology and Orthopedics Service during the
period from June 2014 to June 2015. Blood samples
for biochemical determinations were collected in
pairs with cases and controls in order to avoid sea-
sonal bias in results. The protocol was reviewed
and approved by the Center's Ethics Committee and
all patients gave their informed consent.
The following data were collected: age,
weight, body mass index (BMI), toxic habits (alco-
hol intake and smoking), semi-quantitative cal-
cium intake (1 glass of milk=200 mg/day, 1 milk
derivative=200 mg/day, 1 serving of cheese=200
mg/day), first-degree family history with osteopo-
rotic fracture, treatment with vitamin D supple-
ments and/or antiresorptive drugs. Bone mass was
evaluated in the contralateral hip in the period
between 15-30 days after surgery.
Bone samples were collected from the extrac-
ted femoral head for microstructural analysis and
study of bone biomechanical properties after com-
pression test.
2. Biochemical parameters
To carry out the biochemical determinations,
blood samples were taken from the patients, fas-
ting, in the first 48 hours after surgery. The follo-
wing parameters, related to bone metabolism,
were analyzed: calcium corrected for protein
levels, phosphorus, reabsorption bone remodeling
markers (carboxyl-terminal telopeptide of type I
or β-CTX collagen) and formation (amino terminal
propeptide of procollagen type I or PINP, para-
thormone (PTH), 25-hydroxyvitamin D (25 (OH)
D) and insulin-like growth factor (IGF-I).
Serum levels of corrected calcium and phos-
phorus were assessed using the DAX-96 autoa-
nalyzer. The levels of β-CTX and PINP were analy-
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zed by immunoassay (electro-chemiluminescen-
ce), with the autoanalyzer COBAS e 601 (Roche,
Spain), with coefficients of variation (CV) being
interassayed <7.6% and <4.2%, respectively. Serum
PTH was measured by immunoassay (electro-che-
miluminescence), with autoantibody ADVIA
Centaur (Siemens, Germany), with the CV interas-
say <5.8%. Serum 25(OH)D was analyzed by
direct competitive immunoassay (electro-chemilu-
minescence), with the autoanalyzer LIAISON
(DiaSorin, Italy), with the interassay CV <5.5%.
Finally, serum IGF-I was quantified by immunoas-
say (electro-chemiluminescence), with the autoa-
nalyzer IMMULITE (Siemens, Germany), with CV
interassay being <3.9%.
3. Bone mass evaluation
Bone mineral density of hip and contralateral femo-
ral neck was quantified using dual X-ray densito-
metry (DXA), with a Hologic-Densitometer (Hologic
Inc.). The CV in vivo was 1% (total BMD).
4. Microstructural and biomechanical study of
bone tissue
The analysis of the microstructure and the biome-
chanical properties has been made from the bone
samples taken at the time of the surgical interven-
tion for the prosthesis collation. From each femo-
ral head, a trabecular bone cylinder from the pri-
mary compression region has been extracted with
the longitudinal axis of the cylinder aligned with
the main trabecular direction (MTD) (Figure 1).
Microstructural analysis of the biopsies has
been carried out using computerized microtomo-
graphy (micro-CT) using Bruker SkyScan 1172.
The scanning of the sample was carried out at a
resolution of 11 m, taking 2 images for each step
of sample rotation (0.40°/pass, 180° total rotation).
The images obtained have been reconstructed
using the modified Feldkamp algorithm and later
used for the quantitative and qualitative analysis of
the trabecular bone microstructure.
The quantitative variables were: bone volume
fraction (BV/TV), trabecular thickness (Tb.Th), tra-
becular number (Tb.N), trabecular separation
(Tb.Sp), degree of anisotropy (DA), which is a
measurement of the symmetry of the object, or the
presence/absence of structures aligned in a given
direction, model structure index (MSI), indicating
the relative prevalence of trabeculae in the form of
plates or in the form of tube-cylinder and connec-
tivity (trabecular pattern factor, Tb.Pf), which is an
index of inverse connectivity, so that the higher
the value the less connected the trabeculae are.
To assess biomechanical properties, uniaxial
compression tests were carried out using the IGFA
(image-guided failure analysis), applying a maxi-
mum force of 200 N, without reaching the elastic
resistance limit of the sample. The variables that
were quantified to describe the mechanical beha-
vior of the bone tissue were the maximum stress
(σ), or maximum internal resistance of the object
to a force acting on it. The maximum deformation
(ε), which represents the changes in the dimen-
sions of the object subjected to the action of force,
from which microfractures occur and Young’s
modulus, or elastic modulus, which represents the
slope of the elastic region.
5. Statistical analysis
The IBM SPSS statistical package version 20.0
(USA) was used. For the statistical analysis of the
results of quantitative variables, we carried out
comparisons of Student's t-means for independent
samples. We did univariate linear analysis (ANCO-
VA) to take into account possible confounding fac-
tors such as age and BMI. Pearson's correlation
test was used to assess the association between
variables. To study the qualitative variables, we
have analyzed contingency tables, χ2. In all cases,
a level of p <0.05 was required to consider signi-
ficant differences.
Results
The characteristics of the patients studied in each
of the groups are shown in table 1. As expected,
patients with hip fracture had a significantly hig-
her age, 81±8 vs 68±9 years, p=0.001, a lower BMI
28.2±5.8 vs 31.9±4.4, p=0.043 and lower hip mass
values (p<0.05 for all locations). Since the group
of patients with fracture and osteoarthrosis were
different in terms of age and BMI, the parameters
analyzed were adjusted for these variables. In
terms of habits, family history of first-degree oste-
oporosis, treatment with antiresorptive drugs and
supplementation with vitamin D and calcium were
similar in both groups.
1. Serum values of parameters related to bone
metabolism
The biochemical parameters of the patients studied
are shown in table 2. Serum levels of 25(OH)D
were significantly lower in patients with fracture
than in the group of patients with osteoarthritis
(10.9±6.9 vs 18.1±10.7 ng/mL, p=0.02). The values
of PTH (60±41.1 vs 38.2±17.3 pg/mL, p=0.029) and
the bone resorption marker β-CTX (0.61±0.26 vs
0.36±0.19 ng/mL, p=0.04) were significantly higher
in the first group. Levels of corrected serum cal-
cium, phosphorus, bone formation marker PINP
and IGF-I were comparable in both groups. After
adjustment for age and BMI, we verified that the
differences that we found for 25(OH)D and β-CTX
remained significant. The adjusted values for
25(OH)D were 10.7±(95% CI 6.6-14.7) ng/mL for
the hip fracture group and 19.6±95% CI, 7-25.5)
ng/mL, for that of arthrosic patients, (p=0.027). The
levels of β-CTX adjusted for the same variables
were 0.63±(95% CI 0.51-0.7) ng/mL, in the group of
patients with hip fracture and 0.30±95% 0.1-0.5)
ng/ml in the arthrosis group (p=0.012).
Levels of 25(OH)D showed a significant and
positive correlation with serum IGF-I (r=0.338, p =
0.044) and negative with β-CTX levels (r=-0.483,
p=0.003). PTH levels were significantly negatively
correlated with BMD-hip (r=-0.617, p=0.005) and
positively with trabeculae separation (r=0.530,
p=0.006).
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2. Bone tissue microstructure and biomechanics
Microstructural indices indicate lower bone quality
in the group of patients with hip fracture than the
arthrosic group. In figure 2, we show the result of
scanned images of two patients, each belonging to
a study group.
Although no parameter presented a statistically
significant difference, we verified that the values
of percentage of bone volume, as well as the
thickness and number of trabeculae were lower in
patients with fracture, whereas the separation bet-
ween them was greater (Table 3).
The trabecular pattern index (inverse index of
connectivity) presented higher values in the group
of fractured patients. The structure index of the
model, which implies a relative prevalence of tra-
beculae in the form of tube-cylinder compared to
those of plate form, was higher in the group of
patients with hip fracture, indicating a greater
number of trabeculae in the form of a tube-cylin-
der, less resistant in these patients.
Biomechanics studies showed that Young's
modulus values, maximal strain and maximum
deformation, after applying compression tests,
were lower in patients with hip fracture than in
patients with osteoarthritis, although these diffe-
rences were not significant (Table 3).
3. BMD and bone structure results in patients with
insufficient levels of 25(OH)D (<20 ng/mL)
Serum levels of 25(OH)D in the studied population
have shown very low values, in the range of 4.0-41.6
ng/mL when dividing patients into two groups, con-
sidering that these levels were less than or equal to
20 ng/mL or higher, we found the following results:
the two populations were similar in age, weight,
BMI, bone mass values and biomechanical characte-
ristics of bone tissue. However, those with levels
below 20 ng/mL had higher serum β-CTX values
(0.58±0.25 vs 0.30±0.15 ng/mL, p=0.006), lower IGF-
I (49.8±27.0 vs 83.5±35.6 ng/mL, p=0.007) and the
bone structure showed a smaller trabecular width
(0.34±0.17 vs 0.50±0.1 mm, p=0.04) (Figure 3).
Discussion 
This study allowed us to compare serum levels of
vitamin D in patients with and without osteoporo-
tic hip fracture and the association of these levels
with markers of bone remodeling, hormones regu-
lating bone metabolism, BMD, microstructural
indexes and biomechanical properties of the
femoral neck in these patients.
We found that patients with osteoporotic hip
fracture had significantly lower serum 25(OH)D
levels than non-fractured patients. In addition, we
noted a high prevalence in elderly people with
deficient levels (<20 ng / mL), especially in the OP
group, in line with what was observed by other
authors13-18, despite having approximately 3,000
hours of sunshine per year in our environment. As
is known, insufficient levels of vitamin D are asso-
ciated with an increased risk of falls and osteopo-
rotic fractures11,12. In our study, we also verified
that patients with osteoporotic hip fracture also
present higher serum levels of β-CTX and PTH,
together with lower BMD values in all hip-measu-
red locations, compared to patients without fractu-
re. In addition, we demonstrated a significant
negative correlation between 25(OH)D and β-CTX
levels, as well as between PTH and BMD levels.
Figure 1. Localization of the trabecular bone cylinder extraction for the analysis of the microstructure and
biomechanical properties
MTD = main trabecular direction
≈ 8 mm
≈ 4 mm
M
T
D
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Taken together, these data once again
explain that low levels of 25(OH)D are asso-
ciated with high levels of PTH, that inducing
a greater bone turnover would explain the
higher values of bone remodeling markers.
The imbalance in the levels of these parame-
ters causes trabecular deterioration that could
lead to increased risk of fracture. A high rate
of bone remodeling increases the number of
resorption cavities. These cavities act as
"areas of stress accumulation", foci of weak-
ness that may increase the risk of microfrac-
tures and macrofractures19. Excessive resorp-
tion may also lead to perforation of the trabe-
culae and permanent loss of connectivity. All
these alterations described at the microstruc-
tural level of the trabecular bone make it less
resistant to the load and, therefore, with an
increased risk of fracture20. In our study, all
individuals with non-traumatic hip fracture
and with osteoarthritis, except one in the lat-
ter group, had levels of 25(OH)D <40 ng/mL.
Some authors report that men with radiologi-
Table 1. Characteristics of the study population. Values expressed as mean ± SD
Table 2. Serum values of biochemical parameters of the study population. Values expressed as mean ± SD
OA (n=14) OP (n=29) p
Age (years) 68±9 81±8 p=0.0001
Weight (kg) 77.8±17.9 68.7±13.5 n.s.
BMI (kg/m2) 31.92±4.41 28.22±5.8 p=0.043
BMD neck (g/cm2) 0.733±0.15 0.577±0.09 p=0.008
BMD hip (g/cm2) 0.905±0.14 0.774±0.12 p=0.029
T-score neck -1.3±1.1 -2.5±0.8 p=0.008
T-score hip 0.7±0.8 -1.5±0.9 p=0.034
Smoking 14.3% 11.5% n.s.
Family history in 1st degree of osteoporosis 23.1% 30.8% n.s.
Vitamin D treatment 23.1% 10.5% n.s.
Intake of calcium (mg/day) 770.4±444.8 725.1±252.6 n.s.
OA (n=14) OP (n=29) p
25(OH)D (ng/mL) 18.1±10.7 10.9±6.9 p=0.02
PTH (pg/mL) 38.2±17.3 60±41.1 p=0.029
PINP (ng/mL) 55.8±37.6 57.6±38.0 n.s.
β-CTX (ng/mL) 0.36±0.19 0.61±0.26 p=0.04
Phosphorus (mg/dL) 3.1±0.5 3.1±0.8 n.s.
Corrected calcium (mg/dL) 9.5±0.6 9.4±0.4 n.s.
IGF-I (ng/mL) 66.3±36.6 51.7±29.0 n.s.
A) B)
Figure 2. Reconstruction of scanned images of patient
biopsies with osteoarthritis (A) and hip fracture (B)
n.s.: not significant.
n.s.: not significant.
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cal osteoarthritis of the hip have lower levels of
25(OH)D and a prevalence of deficiency higher
than the control population21. It is generally
known that up to this level of 40 ng/mL an inver-
se relationship between vitamin D and PTH16 is
described. Although a low calcium intake may
also be responsible for increasing PTH levels, in
our case we found that calcium intake was low
but similar in both study groups (<800 mg/day).
Although this is a factor to be taken into account,
we know that insufficient levels of vitamin D lead
to elevated levels of PTH, despite adequate cal-
cium intake, and conversely, sufficient levels of
vitamin D maintain normal levels of PTH despite
calcium intake <800 mg/day22.
Although patients with hip fracture presented
lower BMD values than patients with osteoarthri-
tis at all hip-measured locations, we did not find
an association between these values and serum
levels of 25(OH)D, as reported by other authors23.
However, we would like to point out that when all
patients studied according to their 25(OH)D levels
were <20 ng/mL or higher, the group of patients
with lower levels also had lower levels of hip
BMD, of 0.06 gHA/cm2. These data may not be
important at the individual level, but in terms of
population level, taking into account each decrea-
se of 1 standard deviation (SD), the risk of hip
fracture increases by an average of 2.6 times24,25.
This would imply that, with the lowest bone mass
found, the risk of fracture may be increased up to
1.5 times.
Many experts, based on broad population stu-
dies, have jointly pointed out that minimum levels
of 25(OH)D of at least 20-30 are desirable to main-
tain overall health integrity, and bone in particu-
lar, Ng/mL (50-75 nM)26-29. The negative effect of
insufficient levels of vitamin D on bone has been
assessed by surrogate factors such as PTH, BMD,
and markers of bone remodeling. It has also been
directly analyzed through its association with bone
properties involved in bone strength and, therefo-
re, the risk of fractures. In this sense, it has been
verified by histo-morphometric studies of iliac
crest that vitamin D insufficiency is associated
with mineralization defects, showing higher levels
of surface and volume of osteoid, and concluding
that hormone levels higher than 30 Ng/mL to pre-
vent pathological accumulation of osteoid3. One of
the fundamental aspects of our study is the assess-
ment of microarchitecture and biomechanical pro-
perties of the femoral neck of patients with and
without osteoporotic hip fracture. Although the
differences in the different parameters were not
significant in any of the cases, as has been poin-
ted out by other authors30,31, we found that patients
with hip fracture presented a percentage of bone
volume (BV/TV), a number of trabeculae (Tb.N)
and a width of these (Tb.th) 16%, 15% and 13%
lower, respectively, than those of patients with
osteoarthritis. In addition, the trabeculae were less
connected and predominant than those presented
as cylinder-tube in the fractured group, which is
related to a lower bone resistance32. Along with
this, biomechanical parameters also showed
results between 10-14% lower in patients with hip
fracture. We would like to highlight, as the most
important point of this study, that it analyzes for
the first time the serum levels of vitamin D,
directly related to the microstructural properties of
bone tissue in people with hip fracture. When
comparing hormone levels among patients, we
found that levels below 20 ng/mL were associated
with a significant reduction in trabecular width, in
addition to higher levels of β-CTX, indicating a
greater activity of bone resorption, together with
Table 3. Microstructure and biomechanical bone properties of the study group. Values expressed as mean ± SD
OA (n=14) OP (n=29)
BV/TV (%) 36.2±12.1 30.5±12.9
Tb.th (mm) 0.39±0.2 0.34±0.2
Tb.Sp (mm) 1.02±0.6 1.04±0.5
Tb.N (mm-1) 0.98±0.9 0.83±0.7
Tb.Pf (mm-1) -0.08±4.2 2.81±5.0
SMI 0.44±1.3 1.07±0.8
AD 2.96±0.67 3.43±0.98
Módulo de Young (Mpa) 460±276 397±173
σ (Mpa) 9.1±4.9 8.2±3.6
ε 0.045±0.04 0.039±0.02
BV/TV: bone volume fraction; Tb.th: trabecular thickness; Tb.Sp: trabecular separation; Tb.N: number of tra-
beculae; Tb.Pf: trabecular connectivity; SMI: structural model index; AD: degree of anisotropy; σ: maximum
voltage; ε: maximum deformation.
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lower levels of IGF-I. Vitamin D status reportedly
contributes to the determination of serum IGF-I
levels33. In turn, IGF-I has been shown to stimula-
te renal 1 -hydroxylase activity, contributing to
phospho-calcium metabolism, in addition to bene-
fitting bone mass34, associated with its reduction to
a decrease in bone formation that contributes to
bone loss in senile osteoporosis35.
Our study has several limitations, especially in
terms of sample size, which is relatively small.
Furthermore, the dispersion of results of structural
and mechanical parameters could be remedied, at
least in part, with larger studies.
Overall, given the results obtained, we may
conclude that the elderly population has a defi-
cient vitamin D status, that these levels are even
lower among patients with osteoporotic hip frac-
ture and that serum concentrations below 20
ng/mL of the hormone can, directly or indirectly
through PTH and IGF-I, condition an alteration in
bone remodeling (β-CTX elevation) and BMD,
with a consequent repercussion at the microstruc-
tural level (Tb.Th, among others) that lead to it
being a low resistance bone where fractures easily
occur.
Conclusions
These results indicate that patients with hip fractu-
re have lower levels of 25(OH)D than patients
with osteoarthritis, and that these induce raised
PTH and increased bone resorption (with conse-
quent increase in β-CTX levels) leading to decrea-
sed bone mass, decreased quality and increased
risk of fracture. These alterations are more pro-
nounced in patients with serum levels of 25(OH)D
<20 ng/mL, in which there is also a decrease in
IGF-I and trabecular width at the structural level of
the femoral neck trabecular bone.
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Figure 3. Serum levels of PTH (a), IGF-I (b), β-CTX (c) and Tb.th -trabecular enlargement- (d) of patients with
serum levels of 25(OH)D> 20 ng/ML (n=10) or ≤20 ng/mL (n=33)
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